Finance

Lists
ALKEM:NSE
Alkem Laboratories Ltd
5 185,00 INR
-0,67%
(-35,00) 1D
5 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ALKEM...
Open
5 210,00 INR
High
5 235,00 INR
Low
5 136,00 INR
Mkt. cap
619,94 მლრ.
Avg. vol.
143,43 ათ.
Volume
102,61 ათ.
Dividend
1,02%
Quarterly dividend
13,25 INR
Ex-dividend date
7 აგვ. 2026
P/E ratio
28,73
52-wk high
5 933,50 INR
52-wk low
5 051,00 INR
EPS
180,45 INR
Shares outstanding
119,55 მლნ.
No. of employees
19 ათ.
Open
5 210,00 INR
High
5 235,00 INR
Low
5 136,00 INR
Mkt. cap
619,94 მლრ.
Avg. vol.
143,43 ათ.
Volume
102,61 ათ.
Dividend
1,02%
Quarterly dividend
13,25 INR
Ex-dividend date
7 აგვ. 2026
P/E ratio
28,73
52-wk high
5 933,50 INR
52-wk low
5 051,00 INR
EPS
180,45 INR
Shares outstanding
119,55 მლნ.
No. of employees
19 ათ.
News stories
From web sources and news partners
Profile
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets. Wikipedia
About Alkem Laboratories Ltd
CEO-
Employees19,3 ათ.
Founded1973
Headquartersმუმბაი, მაჰარაშტრა, ინდოეთი
SectorPharmaceutical industry
Websitealkemlabs.com
Last report
14 აგვ. 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
43,49 INR / 47,04 INR
-7,56%miss
Revenue / Est. (INR)
37,40 მლრდ. / 37,96 მლრდ.
-1,46%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
40,01 მლრდ.
37,37 მლრდ.
36,03 მლრდ.
37,40 მლრდ.
Cost of goods sold
14,01 მლრდ.
12,73 მლრდ.
14,33 მლრდ.
12,01 მლრდ.
Cost of revenue
14,01 მლრდ.
12,73 მლრდ.
14,33 მლრდ.
12,01 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,10 მლრდ.
7,22 მლრდ.
17,12 მლრდ.
8,09 მლრდ.
Operating expense
17,73 მლრდ.
17,31 მლრდ.
17,80 მლრდ.
18,73 მლრდ.
Total operating expenses
31,74 მლრდ.
30,04 მლრდ.
32,13 მლრდ.
30,74 მლრდ.
Operating income
8,27 მლრდ.
7,33 მლრდ.
3,90 მლრდ.
6,66 მლრდ.
Other non operating income
1,04 მლრდ.
1,43 მლრდ.
-3,55 მლრდ.
1,53 მლრდ.
EBT including unusual items
8,95 მლრდ.
7,81 მლრდ.
4,22 მლრდ.
7,71 მლრდ.
EBT excluding unusual items
8,95 მლრდ.
8,33 მლრდ.
4,77 მლრდ.
7,71 მლრდ.
Income tax expense
1,16 მლრდ.
1,28 მლრდ.
1,71 მლრდ.
2,50 მლრდ.
Effective tax rate
12,98%
16,35%
40,53%
32,47%
Other operating expenses
9,69 მლრდ.
9,15 მლრდ.
-378,70 მლნ.
9,64 მლრდ.
Net income
7,65 მლრდ.
6,36 მლრდ.
2,36 მლრდ.
5,20 მლრდ.
Net profit margin
19,12%
17,02%
6,56%
13,90%
Earnings per share
63,99
56,88
26,50
43,49
Interest and investment income
-
-
3,92 მლრდ.
-
Interest expense
-350,20 მლნ.
-421,00 მლნ.
-336,50 მლნ.
-466,20 მლნ.
Net interest expenses
-350,20 მლნ.
-421,00 მლნ.
3,58 მლრდ.
-466,20 მლნ.
Depreciation and amortization charges
936,10 მლნ.
950,10 მლნ.
1,06 მლრდ.
1,00 მლრდ.
EBITDA
9,18 მლრდ.
8,11 მლრდ.
4,67 მლრდ.
7,43 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები